NYSE:VNEVeoneer Stock Price, Forecast & News

Veoneer's stock was trading at $8.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VNE shares have increased by 8.7% and is now trading at $9.77.
View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Veoneer.

Veoneer is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Veoneer.

Veoneer Inc (NYSE:VNE) announced its quarterly earnings data on Friday, July, 24th. The company reported ($0.80) earnings per share for the quarter, topping analysts' consensus estimates of ($1.38) by $0.58. The business had revenue of $184 million for the quarter, compared to analysts' expectations of $189.55 million. Veoneer had a negative net margin of 37.71% and a negative return on equity of 29.33%.
View Veoneer's earnings history.

7 brokers have issued 1 year price targets for Veoneer's shares. Their forecasts range from $9.00 to $20.00. On average, they anticipate Veoneer's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 22.8% from the stock's current price.
View analysts' price targets for Veoneer.

Media stories about VNE stock have trended negative this week, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Veoneer earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days.
View the latest news about Veoneer.

Veoneer saw a increase in short interest in July. As of July 15th, there was short interest totaling 7,890,000 shares, an increase of 6.6% from the June 30th total of 7,400,000 shares. Based on an average trading volume of 455,300 shares, the days-to-cover ratio is currently 17.3 days. Currently, 7.1% of the shares of the stock are short sold.
View Veoneer's Current Options Chain.

Some companies that are related to Veoneer include Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Meritor (MTOR), Adient (ADNT), Delphi Technologies (DLPH), Gentherm (THRM), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Tower International (TOWR), Stoneridge (SRI), Tenneco (TEN), Garrett Motion (GTX) and IOCHPE MAXION S/S (IOCJY).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Pfizer (PFE), Autoliv (ALV), Franklin Resources (BEN), Canadian Natural Resources (CNQ), Constellation Pharmaceuticals (CNST), California Resources (CRC), Dominion Energy (D), Delta Air Lines (DAL), Enterprise Products Partners (EPD) and Gilead Sciences (GILD).

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include DNB Asset Management AS (1.32%), First Trust Advisors LP (0.14%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%) and UBS Group AG (0.00%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson and Mathias Hermansson.
View institutional ownership trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, and UBS Group AG.
View insider buying and selling activity for Veoneer.

VNE stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, and Mathias Hermansson.
View insider buying and selling activity for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $9.77.

Veoneer has a market capitalization of $1.09 billion and generates $1.90 billion in revenue each year. The company earns $-500,000,000.00 in net income (profit) each year or ($4.92) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.

The official website for Veoneer is www.veoneer.com.

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at 248-223-0600 or via email at [email protected]